# Potential Questions and Answers for BTech Project Mid-Evaluation

## 1. Why did you choose breast cancer detection as your project topic?

Answer: We chose breast cancer detection for several compelling reasons:

1. Prevalence and impact: Breast cancer affects approximately 12.5% of women in their lifetime, making it one of the most common cancers among women globally. Early detection significantly improves survival rates and patient outcomes.

2. Technological relevance: The integration of machine learning, deep learning, and transfer learning in medical imaging analysis is a cutting-edge field with immense potential for improving diagnostic accuracy.

3. Research gaps: Despite numerous studies, there are still challenges in achieving consistent high accuracy across different imaging modalities. Our project aims to address these gaps by developing a comprehensive model that integrates multiple imaging techniques.

4. Societal impact: Improving breast cancer detection methods can lead to earlier diagnoses, better treatment planning, and ultimately, save lives. This aligns with our goal of applying technology to solve real-world problems.

5. Interdisciplinary nature: This project allows us to combine knowledge from various fields, including computer science, medical imaging, and oncology, providing a rich learning experience.

## 2. Can you explain the significance of using multiple imaging modalities in your project?

Answer: The use of multiple imaging modalities is a key aspect of our project for several reasons:

1. Complementary information: Each imaging modality (mammography, histopathology, and ultrasound) provides unique insights into breast tissue characteristics. By combining these, we can capture a more comprehensive view of potential abnormalities.

2. Increased detection accuracy: Different types of breast cancer may be more visible in certain imaging modalities. By integrating multiple modalities, we increase the likelihood of detecting various types of breast cancer.

3. Reduced false positives/negatives: Some abnormalities may be ambiguous in one modality but clearer in another. Using multiple modalities can help confirm or rule out suspected cases, potentially reducing false positives and false negatives.

4. Addressing limitations: Each modality has its strengths and limitations. For example, mammography is excellent for detecting microcalcifications but may struggle with dense breast tissue. Ultrasound can be more effective in such cases. By combining modalities, we can compensate for individual limitations.

5. Novel approach: While there have been studies on individual modalities, the integration of all three (mammography, histopathology, and ultrasound) using advanced deep learning techniques like InceptionV3 is relatively unexplored, offering potential for significant improvements in breast cancer detection.

## 3. Why did you choose InceptionV3 for your model architecture?

Answer: We selected InceptionV3 for our model architecture due to several advantageous features:

1. Pretrained on ImageNet: InceptionV3 comes pretrained on a large dataset (ImageNet), which provides a robust starting point for feature extraction, even when working with medical images.

2. Efficient architecture: The inception modules in InceptionV3 allow for efficient computation with lower computational cost compared to some other deep architectures, making it suitable for processing large medical imaging datasets.

3. Depth and complexity: With 48 layers, InceptionV3 is deep enough to capture complex features in medical images without being so deep that it becomes unmanageable for our project scope.

4. Multiple convolutional filter sizes: InceptionV3 uses convolutional filters of different sizes (1x1, 3x3, 5x5) within the same layer. This allows the network to capture features at different scales, which is particularly useful for detecting various sizes of abnormalities in breast images.

5. Handles image variability: The architecture of InceptionV3 is designed to handle variations in the position and scale of features within images. This is crucial for medical imaging, where abnormalities can vary significantly in size and location.

6. Proven performance: InceptionV3 has shown excellent performance in various image classification tasks, including some medical imaging applications, making it a promising choice for our breast cancer detection project.

7. Transfer learning potential: The architecture of InceptionV3 is well-suited for transfer learning, allowing us to fine-tune the model for our specific task of breast cancer detection across multiple imaging modalities.

## 4. How does your data preprocessing pipeline work, and why are these steps important?

Answer: Our data preprocessing pipeline includes several key steps, each serving a specific purpose in preparing the images for our model:

1. Histogram Equalization:
   - Process: This technique adjusts the global contrast of the image.
   - Importance: It helps to enhance the visibility of features in the image, particularly useful for mammograms where subtle differences can be crucial for detection.

2. Negative Transformation:
   - Process: This inverts the intensity values of the image.
   - Importance: In some medical imaging modalities, like X-rays, negatives can make certain features more visible to both human eyes and our model.

3. Image Rescaling:
   - Process: We rescale the pixel values to a range of [0, 1].
   - Importance: This normalization step ensures that all input values are on a similar scale, which can help with the stability and performance of the neural network.

4. Image Resizing:
   - Process: All images are resized to 224x224 pixels.
   - Importance: This ensures a consistent input size for the InceptionV3 model, which expects images of this dimension.

5. Data Augmentation (planned for future iterations):
   - Process: Techniques like rotation, scaling, and flipping will be applied to the training images.
   - Importance: This will increase the diversity of our training data, helping the model generalize better and potentially addressing class imbalance issues.

These preprocessing steps are crucial because they:
- Enhance the quality and consistency of the input data
- Highlight important features that might be subtle in the original images
- Prepare the data in a format suitable for our chosen model architecture
- Help in managing variations in image quality and characteristics across different imaging modalities and equipment

By implementing this preprocessing pipeline, we aim to provide our model with the best possible input data, potentially leading to improved detection accuracy and robustness.

## 5. How do you plan to evaluate the performance of your model?

Answer: We plan to evaluate the performance of our model using a comprehensive approach:

1. Metrics:
   - Accuracy: Overall correctness of the model's predictions.
   - Sensitivity (Recall): Ability to correctly identify positive cases (true positive rate).
   - Specificity: Ability to correctly identify negative cases (true negative rate).
   - Precision: Proportion of positive identifications that are actually correct.
   - F1 Score: Harmonic mean of precision and recall, providing a balanced measure.
   - Area Under the ROC Curve (AUC-ROC): Evaluates the model's ability to distinguish between classes.

2. Cross-Validation:
   - We'll use k-fold cross-validation to ensure our results are robust and not biased by a particular split of the data.

3. Comparison with Existing Methods:
   - We'll compare our model's performance with the results from previous studies mentioned in our literature survey (e.g., the 98.13% accuracy achieved by Fractal Dimension + SVM, and the 99.6% accuracy reported for some transfer learning methods).

4. Performance Across Modalities:
   - We'll evaluate how well our model performs on each imaging modality individually (mammography, histopathology, ultrasound) as well as in combination.

5. Confusion Matrix Analysis:
   - We'll analyze the confusion matrix to understand the types of errors our model makes (false positives vs. false negatives) and their potential clinical implications.

6. Visualization Techniques:
   - We plan to use techniques like Grad-CAM (Gradient-weighted Class Activation Mapping) to visualize which parts of the images are most influential in the model's decisions. This can help in interpreating the model's behavior and potentially validate its focus on clinically relevant areas.

7. External Validation:
   - If possible, we aim to test our model on a separate, external dataset to evaluate its generalization capabilities.

8. Statistical Significance:
   - We'll perform statistical tests to ensure that our model's performance improvements are significant and not due to chance.

9. Error Analysis:
   - We'll conduct a detailed analysis of the cases where our model fails, to understand its limitations and identify potential areas for improvement.

By using this multi-faceted evaluation approach, we aim to gain a comprehensive understanding of our model's performance, its strengths, and areas for potential improvement. This will also help us assess how well we've addressed the challenges identified in previous studies, such as consistency across different imaging modalities.

## 6. What are the main challenges you've encountered so far, and how are you addressing them?

Answer: In the course of our project, we've encountered several challenges:

1. Data Integration:
   - Challenge: Combining data from different imaging modalities (mammography, histopathology, ultrasound) with varying resolutions, scales, and features.
   - Solution: We're developing a robust preprocessing pipeline to normalize and standardize inputs across modalities. We're also exploring advanced data fusion techniques at different levels of our model architecture.

2. Class Imbalance:
   - Challenge: In medical datasets, there's often an imbalance between normal and abnormal cases.
   - Solution: We plan to implement data augmentation techniques specifically for the minority class. We're also considering advanced sampling techniques like SMOTE (Synthetic Minority Over-sampling Technique) and adjusting class weights in our loss function.

3. Model Complexity vs. Computational Resources:
   - Challenge: Balancing the depth and complexity of our model with available computational resources.
   - Solution: We chose InceptionV3 for its efficiency. We're also implementing techniques like gradient checkpointing to manage memory usage and exploring cloud computing options for training.

4. Interpretability:
   - Challenge: Ensuring our model's decisions are interpretable for clinical use.
   - Solution: We're planning to implement visualization techniques like Grad-CAM. We're also exploring attention mechanisms that can highlight which parts of the image are most influential in the model's decision.

5. Generalization:
   - Challenge: Ensuring our model performs well across different datasets and real-world scenarios.
   - Solution: We're using cross-validation and plan to test on external datasets if possible. We're also implementing robust data augmentation to expose our model to a wide variety of image variations.

6. Ethical Considerations:
   - Challenge: Addressing potential biases in the dataset and ensuring patient privacy.
   - Solution: We're carefully examining our datasets for potential biases (e.g., demographic representation) and implementing strict data anonymization protocols.

7. Performance Benchmarking:
   - Challenge: Accurately comparing our results with existing methods, given variations in datasets and evaluation metrics across studies.
   - Solution: We're standardizing our evaluation metrics and, where possible, implementing baseline models from previous studies to allow for direct comparisons.

By actively addressing these challenges, we aim to develop a robust, accurate, and clinically relevant breast cancer detection model. We're constantly reviewing literature and consulting with our supervisor to find the most effective solutions to these ongoing challenges.

## 7. How do you ensure the reliability and generalizability of your model, considering the variability in medical imaging equipment and techniques?

Answer: Ensuring reliability and generalizability is crucial for our model's potential real-world application. We're addressing this through several strategies:

1. Diverse Dataset:
   - We're using datasets from multiple sources (CBIS-DDSM, BreakHis, BUSI) which inherently include images from various equipment and institutions.
   - This diversity helps our model learn features that are consistent across different imaging setups.

2. Data Augmentation:
   - We plan to implement extensive data augmentation techniques that mimic real-world variations in image acquisition, such as changes in contrast, brightness, and noise levels.
   - This exposes our model to a wider range of image characteristics, improving its ability to generalize.

3. Transfer Learning:
   - By using InceptionV3 pretrained on a large, diverse dataset (ImageNet), we start with a model that has already learned to recognize a wide variety of features.
   - We then fine-tune this model on our specific medical imaging datasets.

4. Multi-modal Approach:
   - By incorporating multiple imaging modalities (mammography, histopathology, ultrasound), we reduce reliance on any single imaging technique.
   - This multi-modal approach can help compensate for variations or limitations in any single modality.

5. Robust Preprocessing:
   - Our preprocessing pipeline, including histogram equalization and image normalization, helps standardize inputs regardless of the original image characteristics.
   - This reduces the impact of variations in imaging equipment and techniques.

6. Cross-validation:
   - We use k-fold cross-validation to ensure our model's performance is consistent across different subsets of our data.

7. Testing on Unseen Data:
   - We plan to evaluate our model on a separate test set that it hasn't seen during training or validation.
   - If possible, we aim to test on external datasets from different institutions to truly assess generalizability.

8. Collaboration with Medical Professionals:
   - We're seeking input from radiologists and oncologists to ensure our model is focusing on clinically relevant features and not overfitting to dataset-specific artifacts.

9. Uncertainty Quantification:
   - We're exploring techniques to quantify our model's uncertainty in its predictions. This can help identify cases where the model might be less reliable due to unfamiliar image characteristics.

10. Continuous Monitoring and Updating:
    - While beyond the scope of our current project, we recognize that in a real-world deployment, continuous monitoring and periodic retraining would be necessary to maintain performance across evolving imaging technologies.

By implementing these strategies, we aim to develop a model that is not only accurate on our specific datasets but also robust and generalizable to the variations encountered in real-world clinical settings. This approach aligns with our goal of creating a practically applicable tool for breast cancer detection.

## 8. How does your project address the ethical considerations and potential biases in AI-based medical diagnosis?

Answer: Ethical considerations and potential biases are crucial aspects of AI in medical diagnosis. Our project addresses these concerns through several measures:

1. Data Diversity and Representation:
   - We're using datasets from multiple sources to ensure diversity in our training data.
   - We're analyzing the demographic information available in our datasets to understand any potential underrepresentation.
   - In future iterations, we aim to actively seek out datasets that represent diverse populations.

2. Transparency in Model Development:
   - We're maintaining detailed documentation of our data sources, preprocessing steps, and model architecture.
   - This transparency allows for peer review and validation of our methods.

3. Interpretability:
   - We're implementing visualization techniques like Grad-CAM to make our model's decision-making process more interpretable.
   - This helps in building trust and allows medical professionals to validate the model's focus areas.

4. Privacy Protection:
   - We're working only with anonymized datasets to protect patient privacy.
   - Our model development process doesn't involve access to personally identifiable information.

5. Model as an Assistive Tool:
   - We're framing our model as a supportive tool for medical professionals, not a replacement.
   - This approach acknowledges the importance of human expertise in medical decision-making.

6. Performance Across Subgroups:
   - We plan to analyze our model's performance across different subgroups (e.g., age groups, breast density categories) to identify any disparities in accuracy.

7. Bias Detection and Mitigation:
   - We're implementing techniques to detect potential biases in our model's predictions.
   - If biases are detected, we plan to use bias mitigation techniques such as reweighting or adversarial debiasing.

8. Collaboration with Domain Experts:
   - We're seeking input from medical professionals to ensure our model aligns with clinical needs and ethical standards.

9. Addressing Class Imbalance:
   - We're implementing techniques to handle class imbalance, ensuring our model doesn't unfairly favor majority classes.

10. Continuous Evaluation:
    - We recognize the need for ongoing evaluation and adjustment of AI models in medical settings.
    - While beyond our current project scope, we understand that real-world implementation would require continuous monitoring for emerging biases or performance drift.

11. Ethical Guidelines Compliance:
    - We're aligning our project with established ethical guidelines for AI in healthcare, such as those provided by the World Health Organization and other relevant bodies.

12. Limitations Disclosure:
    - We're clearly documenting the limitations of our model, including the specific conditions and populations it has been trained on.
    - This helps prevent misapplication of the model in unsuitable contexts.

By addressing these ethical considerations, we aim to develop a model that is not only technically proficient but also responsible and trustworthy for potential clinical application. We understand that ethical AI in healthcare is an ongoing process, and we're committed to continually refining our approach as new standards and best practices emerge.

## 9. What are your plans for future work on this project?

Answer: Our plans for future work on this project encompass several key areas:

1. Model Refinement:
   - Fine-tuning hyperparameters to optimize performance
   - Experimenting with ensemble methods, combining multiple models for improved accuracy
   - Exploring more advanced architectures, such as Vision Transformers, for potential performance gains

2. Data Enhancement:
   - Implementing more sophisticated data augmentation techniques
   - Seeking additional datasets to increase diversity and volume of training data
   - Exploring synthetic data generation techniques to address class imbalance and rare case representation

3. Multimodal Integration:
   - Developing more advanced techniques for fusing information from different imaging modalities
   - Investigating the use of graph neural networks for representing relationships between different modalities

4. Clinical Validation:
   - Collaborating with medical professionals for real-world testing and feedback
   - Conducting user studies to assess the model's impact on clinical decision-making processes

5. Interpretability and Explainability:
   - Implementing more advanced visualization techniques for model interpretation
   - Developing methods to provide textual explanations for the model's decisions

6. Deployment Considerations:
   - Optimizing the model for efficient inference on various hardware platforms
   - Developing a user-friendly interface for potential clinical use

7. Ethical AI and Bias Mitigation:
   - Conducting more comprehensive bias analysis across various demographic groups
   - Implementing advanced fairness constraints in the model training process

8. Longitudinal Analysis:
   - Exploring the possibility of incorporating temporal data to track changes in imaging over time
   - Developing models that can predict future cancer risk based on current and historical imaging data

9. Integration with Other Data Sources:
   - Investigating the potential of incorporating non-imaging data (e.g., genetic information, patient history) to enhance prediction accuracy

10. Comparative Studies:
    - Conducting more rigorous comparisons with existing commercial and research-based breast cancer detection systems

11. Edge Case Handling:
    - Focusing on improving performance on difficult-to-detect or rare types of breast cancer

12. Privacy-Preserving Techniques:
    - Exploring federated learning or other privacy-preserving machine learning techniques to enable model training across multiple institutions without sharing sensitive data

These future directions aim to not only improve the technical performance of our model but also address broader considerations necessary for real-world clinical application. We're excited about the potential impact of these enhancements on breast cancer detection and patient care.

## 10. How does your project contribute to the broader field of AI in healthcare?

Answer: Our project contributes to the broader field of AI in healthcare in several significant ways:

1. Multimodal Integration:
   - By combining mammography, histopathology, and ultrasound data, our project demonstrates the potential of integrating multiple imaging modalities for more comprehensive disease detection.
   - This approach could be extended to other medical domains where multiple types of diagnostic information are available.

2. Transfer Learning in Medical Imaging:
   - Our use of InceptionV3, pretrained on non-medical images and adapted for breast cancer detection, showcases the potential of transfer learning in specialized medical applications.
   - This contributes to the ongoing discussion about the effectiveness of general-purpose versus domain-specific pre-training in medical AI.

3. Addressing Data Challenges:
   - Our strategies for dealing with limited and imbalanced medical datasets (like data augmentation and careful preprocessing) contribute to the broader conversation about developing robust AI models with constrained data â€“ a common challenge in healthcare AI.

4. Interpretability in Critical Decisions:
   - By focusing on making our model's decisions interpretable, we're contributing to the crucial area of explainable AI in healthcare, which is essential for building trust and enabling clinical adoption.

5. Ethical AI Development:
   - Our approach to addressing biases and ensuring diverse representation in our datasets contributes to the ongoing efforts to develop fair and equitable AI systems in healthcare.

6. Bridging Disciplines:
   - This project demonstrates the interdisciplinary nature of healthcare AI, combining expertise from computer science, medical imaging, and oncology. It serves as a case study for collaborative research across these fields.

7. Potential for Early Detection:
   - By aiming to improve the accuracy of breast cancer detection, our project contributes to the broader goal of early disease detection, which has significant implications for patient outcomes and healthcare economics.

8. Scalable Healthcare Solutions:
   - Our work explores how AI can potentially augment and assist healthcare professionals, contributing to discussions about scalable solutions to healthcare challenges, particularly in regions with limited access to specialist care.

9. Methodological Contributions:
   - The preprocessing pipeline and model architecture we've developed could potentially be adapted for other medical imaging tasks, contributing reusable components to the field.

10. Open Questions in Medical AI:
    - Our project engages with several open questions in the field, such as the optimal ways to combine multiple data modalities, handle class imbalance in medical data, and ensure model generalizability across different patient populations and equipment types.

11. AI Governance in Healthcare:
    - By addressing ethical considerations and bias mitigation, our project contributes to the ongoing dialogue about governance and responsible deployment of AI in healthcare settings.

12. Benchmark for Future Research:
    - Upon completion, our model and methodology could serve as a benchmark for future breast cancer detection systems, contributing to the iterative progress in this field.

Through these contributions, our project not only aims to advance breast cancer detection specifically but also to push forward the broader field of AI in healthcare. We hope our work will inspire further research and development in using AI to improve medical diagnostics and patient care.

## 11. Can you explain how your model handles the variability in breast tissue density, which is known to affect cancer detection in traditional mammography?

Answer: Handling variability in breast tissue density is indeed a crucial aspect of our project, as it significantly affects cancer detection, especially in traditional mammography. Our approach addresses this challenge through several strategies:

1. Multimodal Imaging:
   - By incorporating ultrasound and histopathology alongside mammography, we reduce reliance on any single modality. Ultrasound, in particular, is known to be more effective in detecting abnormalities in dense breast tissue.

2. Advanced Preprocessing:
   - Our preprocessing pipeline, including histogram equalization, helps to enhance contrast in images, potentially making subtle differences more apparent even in dense tissue.

3. Data Augmentation:
   - We plan to implement augmentation techniques that mimic variations in breast density. This will expose our model to a wide range of tissue densities during training, improving its ability to generalize.

4. Density-Aware Training:
   - If available in our datasets, we aim to use breast density information as an additional input feature. This could help the model adjust its interpretation based on the known density of the breast tissue.

5. Transfer Learning Advantage:
   - The InceptionV3 architecture, pretrained on a diverse set of images, has the potential to capture a wide range of textures and patterns. This foundational ability, when fine-tuned on our medical images, may help in distinguishing abnormalities even in varied tissue densities.

6. Attention Mechanisms:
   - We're exploring the integration of attention mechanisms in our model architecture. These could help the model focus on relevant areas regardless of overall tissue density.

7. Separate Density Classification:
   - We're considering implementing a separate branch in our model to classify breast density. This could provide additional context for the main classification task.

8. Ensemble Approaches:
   - In future iterations, we may develop separate models optimized for different breast density categories and ensemble their predictions.

9. Performance Analysis by Density:
   - We plan to analyze our model's performance across different breast density categories to ensure consistent accuracy and identify areas for improvement.

10. Collaboration with Radiologists:
    - We're seeking input from experienced radiologists to understand how they adjust their interpretations for different breast densities, and we're exploring ways to incorporate this expertise into our model.

11. Region-Based Analysis:
    - We're investigating techniques to analyze different regions of the breast separately, which could help in detecting abnormalities in specific areas that might be obscured in a global analysis of dense tissue.

12. Comparative Modality Performance:
    - We'll analyze how our model's performance varies across different imaging modalities for breasts of different densities. This could provide insights into which modalities are most effective for different tissue characteristics.

By implementing these strategies, we aim to develop a model that maintains high detection accuracy across various breast tissue densities. This approach aligns with the clinical need for reliable detection methods, especially for women with dense breast tissue who are at higher risk of both developing breast cancer and having it missed by traditional screening methods.

## 12. How do you envision your model being integrated into clinical workflows, and what challenges do you foresee in this integration?

Answer: Integrating our AI model into clinical workflows is a complex process that requires careful consideration of both technical and practical aspects. Here's how we envision this integration and the challenges we foresee:

Integration Vision:
1. Screening Assistance:
   - Our model could serve as a "second reader" in screening mammography, flagging potential abnormalities for radiologist review.
   - It could prioritize cases in the radiologist's workflow, bringing potentially high-risk cases to immediate attention.

2. Multimodal Analysis:
   - In cases where multiple imaging modalities are available, our model could provide an integrated analysis, potentially highlighting areas of concern across different imaging types.

3. Decision Support Tool:
   - The model could provide quantitative risk assessments and visual heatmaps to aid radiologists in their decision-making process.

4. Triage in Resource-Limited Settings:
   - In areas with limited access to specialist radiologists, the model could help prioritize cases that need urgent expert review.

5. Continual Learning:
   - With proper privacy safeguards, the system could be designed to improve over time based on feedback and new data from clinical use.

6. Integration with Electronic Health Records (EHR):
   - The model's outputs could be integrated into EHR systems, providing a comprehensive view of a patient's breast health over time.

Challenges and Considerations:
1. Regulatory Approval:
   - Obtaining necessary approvals (e.g., FDA clearance) for clinical use will be a significant hurdle, requiring extensive validation studies.

2. Clinical Validation:
   - Conducting large-scale, prospective studies to prove the model's efficacy and safety in real-world clinical settings.

3. Integration with Existing Systems:
   - Ensuring compatibility with various Picture Archiving and Communication Systems (PACS) and other existing healthcare IT infrastructure.

4. Training and Adoption:
   - Developing training programs for healthcare professionals to effectively use and interpret the model's outputs.
   - Overcoming potential resistance to change in established clinical workflows.

5. Liability and Responsibility:
   - Clarifying the legal and ethical responsibilities when AI is involved in diagnostic processes.

6. Explainability and Trust:
   - Ensuring the model's decision-making process is sufficiently transparent for clinicians to trust and verify its suggestions.

7. Handling Edge Cases:
   - Ensuring the model can gracefully handle unusual or rare presentations of disease, and clearly indicate when it's operating outside its area of confidence.

8. Data Privacy and Security:
   - Implementing robust data protection measures to comply with healthcare data regulations like HIPAA.

9. Scalability and Performance:
   - Ensuring the system can handle the high volume of imaging data in busy clinical settings without introducing delays.

10. Bias and Fairness:
    - Continuously monitoring and mitigating any biases that may emerge when the model is applied to diverse patient populations.

11. Cost-Effectiveness:
    - Demonstrating the economic value of integrating the AI system into clinical workflows.

12. Continuous Monitoring and Updating:
    - Establishing processes for monitoring the model's performance over time and updating it as needed without disrupting clinical operations.

13. Ethical Considerations:
    - Addressing ethical concerns about the role of AI in critical healthcare decisions and ensuring it complements rather than replaces human expertise.

By anticipating these challenges and working closely with healthcare professionals, regulatory bodies, and IT specialists, we aim to develop an integration strategy that enhances breast cancer detection while seamlessly fitting into existing clinical workflows. This approach requires ongoing collaboration and iteration to ensure that the technology truly serves the needs of both patients and healthcare providers.
